EFFECT OF INTERLEUKIN-2 ON INTRACTABLE HERPES-VIRUS INFECTION AND CHRONIC ECZEMATOID DERMATITIS IN A PATIENT WITH WISKOTT-ALDRICH SYNDROME

被引:15
作者
AZUMA, H
SAKATA, H
SAIJYOU, M
OKUNO, A
机构
[1] Department of Paediatrics, Asahikawa Medical College, Asahikawa
关键词
RECOMBINANT IL2; WISKOTT-ALDRICH SYNDROME; ATOPIC DERMATITIS; HERPES VIRUS INFECTION;
D O I
10.1007/BF01957224
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Recombinant interleukin 2 (rIL2) was administered to a patient with Wiskott-Aldrich syndrome for the treatment of an intractabel facial herpetiforme lesion. This treatment appeared to be effective in suppressing the virus activity. At the same time, a transient improvement of the chronic eczematoid dermatitis was observed. During rIL2 administration, the CD3+ and CD4+ subsets of peripheral blood lymphocytes increased in number. These changes might play an important role in the induction of anti-viral immunity and in the improvement of dermatits.
引用
收藏
页码:998 / 1000
页数:3
相关论文
共 15 条
[1]  
BICHTHUY LT, 1987, J IMMUNOL, V139, P1550
[2]  
CHIEN CH, 1990, PEDIATRICS, V86, P937
[3]   ADHESIVE AND DEGRADATIVE PROPERTIES OF HUMAN PLACENTAL CYTOTROPHOBLAST CELLS-INVITRO [J].
FISHER, SJ ;
CUI, TY ;
LI, Z ;
HARTMAN, L ;
GRAHL, K ;
ZHANG, GY ;
TARPEY, J ;
DAMSKY, CH .
JOURNAL OF CELL BIOLOGY, 1989, 109 (02) :891-902
[4]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
GRIMM, EA ;
MAZUMDER, A ;
ZHANG, HZ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841
[5]   INTERLEUKIN-2 AUGMENTS NATURAL-KILLER CELL-ACTIVITY [J].
HENNEY, CS ;
KURIBAYASHI, K ;
KERN, DE ;
GILLIS, S .
NATURE, 1981, 291 (5813) :335-338
[6]   INTERLEUKIN-2 ENHANCES NATURAL KILLING OF NORMAL LYMPHOCYTES [J].
MIYASAKA, N ;
DARNELL, B ;
BARON, S ;
TALAL, N .
CELLULAR IMMUNOLOGY, 1984, 84 (01) :154-162
[7]  
OCHS HD, 1980, BLOOD, V55, P243
[8]   RECOMBINANT INTERLEUKIN-2 THERAPY IN SEVERE COMBINED IMMUNODEFICIENCY DISEASE [J].
PAHWA, R ;
CHATILA, T ;
PAHWA, S ;
PARADISE, C ;
DAY, NK ;
GEHA, R ;
SCHWARTZ, SA ;
SLADE, H ;
OYAIZU, N ;
GOOD, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :5069-5073
[9]   A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].
ROSENBERG, SA ;
LOTZE, MT ;
MUUL, LM ;
CHANG, AE ;
AVIS, FP ;
LEITMAN, S ;
LINEHAN, WM ;
ROBERTSON, CN ;
LEE, RE ;
RUBIN, JT ;
SEIPP, CA ;
SIMPSON, CG ;
WHITE, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897
[10]  
ROUSE BT, 1985, J IMMUNOL, V134, P926